Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Expression profiling of epithelial plasticity in tumor progression

Abstract

Epithelial-to-mesenchymal transition (EMT), a switch of polarized epithelial cells to a migratory, fibroblastoid phenotype, is increasingly considered as an important event during malignant tumor progression and metastasis. To identify molecular players involved in EMT and metastasis, we performed expression profiling of a set of combined in vitro/in vivo cellular models, based on clonal, fully polarized mammary epithelial cells. Seven closely related cell pairs were used, which were modified by defined oncogenes and/or external factors and showed specific aspects of epithelial plasticity relevant to cell migration, local invasion and metastasis. Since mRNA levels do not necessarily reflect protein levels in cells, we used an improved expression profiling method based on polysome-bound RNA, suitable to analyse global gene expression on Affymetrix chips. A substantial fraction of all regulated genes was found to be exclusively controlled at the translational level. Furthermore, profiling of the above multiple cell pairs allowed one to identify small numbers of genes by cluster analysis, specifically correlating gene expression with EMT, metastasis, scattering and/or oncogene function. A small set of genes specifically regulated during EMT was identified, including key regulators and signaling pathways involved in cell proliferation, epithelial polarity, survival and trans-differentiation to mesenchymal-like cells with invasive behavior.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Anderson NL and Anderson NG . (1998). Electrophoresis, 19, 1853–1861.

  • Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, Torsney E, Charlton R, Parums DV, Jowett T, Marchuk DA, Burn J and Diamond AG . (2000). Dev. Biol., 217, 42–53.

  • Berquin IM and Sloane BF . (1996). Adv. Exp. Med. Biol., 389, 281–294.

  • Boyer B, Valles AM and Edme N . (2000). Biochem. Pharmacol., 60, 1091–1099.

  • Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R and Kirchner T . (2001). Proc. Natl. Acad. Sci. USA, 98, 10356–10361.

  • Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA . (2000). Nat. Cell Biol., 2, 76–83.

  • Carballo E, Lai WS and Blackshear PJ . (1998). Science, 281, 1001–1005.

  • Christofori G and Semb H . (1999). Trends Biochem. Sci., 24, 73–76.

  • Damm K, Hemmann U, Garin-Chesa P, Hauel N, Kauffmann I, Priepke H, Niestroj C, Daiber C, Enenkel B, Guilliard B, Kraut N and Rettig W . (2001). EMBO J., 20, 6958–6968.

  • D'Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M and Curran T . (1999). Neuron, 24, 471–479.

  • de Jong JS, van Diest PJ, van der Valk P and Baak JP . (1998). J. Pathol., 184, 44–52.

  • Downward J . (1998). Curr. Opin. Cell Biol., 10, 262–267.

  • Eger A, Stockinger A, Schaffhauser B, Beug H and Foisner R . (2000). J. Cell Biol., 148, 173–188.

  • Fambrough D, McClure K, Kazlauskas A. and Lander ES . (1999). Cell, 97, 727–741.

  • Gotzmann J, Huber H, Thallinger C, Wolschek M, Jansen B, Sculte-Hermann R, Beug H and Mikulits W . (2002). J. Cell Sci., 115, 1189–1202.

  • Grünert S, Jechlinger M and Beug Hec . (2003). Nat. Rev. Mol. Cell Biol., 4, 657–665.

  • Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70.

  • Hay ED . (1995). Acta Anat., 154, 8–20.

  • Hocevar BA, Smine A, Xu XX and Howe PH . (2001). EMBO J., 20, 2789–2801.

  • Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H and Grunert S . (2002a). J. Cell Biol., 156, 299–313.

  • Janda E, Litos G, Grunert S, Downward J and Beug H . (2002b). Oncogene, 21, 5148–5159.

  • Kiemer AK, Takeuchi K and Quinlan MP . (2001). Oncogene, 20, 6679–6688.

  • Kumar S, Ghellal A, Li C, Byrne G, Haboubi N, Wang JM and Bundred N . (1999). Cancer Res., 59, 856–861.

  • Lehmann K, Janda E, Pierreux CE, Rytömaa M, Schulze A, McMahon M, Hill CS, Beug H and Downward J . (2000). Genes Dev., 14, 2610–2622.

  • Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H and Brown EL . (1996). Nat. Biotechnol., 14, 1675–1680.

  • Mikulits W, Pradet-Balade B, Habermann B, Beug H, Garcia-Sanz JA and Mullner EW . (2000). FASEB J., 14, 1641–1652.

  • Muraoka RS, Dumont N, Ritter CA, Dugger TC, Brantley DM, Chen J, Easterly E, Roebuck LR, Ryan S, Gotwals PJ, Koteliansky V and Arteaga CL . (2002). J. Clin. Invest., 109, 1551–1559.

  • Murthy A, Gonzalez-Agosti C, Cordero E, Pinney D, Candia C, Solomon F, Gusella J and Ramesh V . (1998). J. Biol. Chem., 273, 1273–1276.

  • Nieto MA, Sargent MG, Wilkinson DG and Cooke J . (1994). Science, 264, 835–839.

  • Oft M, Heider KH and Beug H . (1998). Curr. Biol., 8, 1243–1252.

  • Oft M, Peli J, Rudaz C, Schwarz H, Beug H and Reichmann E . (1996). Genes Dev., 10, 2462–2477.

  • Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO and Botstein D . (1999). Proc. Natl. Acad. Sci. USA, 96, 9212–9217.

  • Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D . (2000). Nature, 406, 747–752.

  • Petersen OW, Nielsen HL, Gudjonsson T, Villadsen R, Rank F, Niebuhr E, Bissell MJ and Ronnov-Jessen L . (2003). Am. J. Pathol., 162, 391–402.

  • Reichmann E, Schwarz H, Deiner EM, Leitner I, Eilers M, Busslinger M and Beug H . (1992). Cell, 71, 1103–1116.

  • Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A and Downward J . (1997). Cell, 89, 457–467.

  • Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D and Brown PO . (2000). Nat. Genet., 24, 227–235.

  • Sager R . (1997). Proc. Natl. Acad. Sci. USA, 94, 952–955.

  • Schulze A, Lehmann K, Jefferies HB, McMahon M and Downward J . (2001). Genes Dev., 15, 981–994.

  • Thiery JP . (2002). Nat. Rev. Cancer, 2, 442–454.

  • Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer RE, Richardson JA and Herz J . (1999). Cell, 97, 689–701.

  • Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M and DuBois RN . (1998). Cell, 93, 705–716.

  • van ‘t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH . (2002). Nature, 415, 530–536.

  • Vignais ML and Gilman M . (1999). Mol. Cell Biol., 19, 3727–3735.

  • Webb DJ, Nguyen DH, Sankovic M and Gohia SL . (1999). J. Biol. Chem., 274, 7412–7420.

  • Yang YA, Dukhanina O, Tang B, Mamura M, Letterio JJ, MacGregor J, Patel SC, Khozin S, Liu ZY, Green J, Anver MR, Merlino G and Wakefield LM . (2002). J. Clin. Invest., 109, 1607–1615.

  • Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, Piek E and Bottinger EP . (2001). Proc. Natl. Acad. Sci. USA, 98, 6686–6691.

  • Zhang H, Reynaud S, Kloc M, Etkin LD and Spohr G . (1995). Mech. Dev., 50, 119–130.

  • Zhou J and Hsieh JT . (2001). J. Biol. Chem., 276, 27793–27798.

  • Zong Q, Schummer M, Hood L and Morris DR . (1999). Proc. Natl. Acad. Sci. USA, 96, 10632–10636.

Download references

Acknowledgements

We thank G Wirl for providing us with the tenascin C antibody. We also thank G Loeber, E Müllner and M Huber for advice and comments on the manuscript, K Quast, A Köhler, K Fiesel for bioinformatics support, and G Litos, W Rust, E Brickl, D Knebel, A Ackermann and A Fischbach for expert technical assistance. Finally, we are particularly grateful to A Eger and R Foisner for help with comparing TGFβ1/3 mRNA and protein expression in FosER cells. This work was supported by grants from an EU TMR network (ERBFMRXCT-980197), from the Austrian Research funding agency (FWF; SFB 006/612) and the Austrian Industrial Research Promotion Fund (FFF project No. 803776).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hartmut Beug.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jechlinger, M., Grunert, S., Tamir, I. et al. Expression profiling of epithelial plasticity in tumor progression. Oncogene 22, 7155–7169 (2003). https://doi.org/10.1038/sj.onc.1206887

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206887

Keywords

Search

Quick links